Praxis Precision Medicines (PRAX) had the highest return between January 2, 2024 and January 22, 2024 by a small-cap US stock, returning 74.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Praxis Precision Medicines (PRAX) | 1/2/2024 - 1/22/2024 | 74.55% |
Real Brokerage (REAX) | 1/2/2024 - 1/22/2024 | 62.89% |
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW) | 1/2/2024 - 1/22/2024 | 62.16% |
Dianthus Therapeutics (DNTH) | 1/2/2024 - 1/22/2024 | 59.52% |
Clene (CLNNW) | 1/2/2024 - 1/22/2024 | 56.52% |
Akso Health Group ADR (AHG) | 1/2/2024 - 1/22/2024 | 51.19% |
Neuropace (NPCE) | 1/2/2024 - 1/22/2024 | 47.96% |
Establishment Labs (ESTA) | 1/2/2024 - 1/22/2024 | 47.39% |
QuantaSing Group Limited American Depositary Shares (QSG) | 1/2/2024 - 1/22/2024 | 47.06% |
Immunome (IMNM) | 1/2/2024 - 1/22/2024 | 44.91% |
Ardelyx (ARDX) | 1/2/2024 - 1/22/2024 | 43.65% |
Edgewise Therapeutics (EWTX) | 1/2/2024 - 1/22/2024 | 42.27% |
Advent Technologies (ADNWW) | 1/2/2024 - 1/22/2024 | 40.85% |
Keros Therapeutics (KROS) | 1/2/2024 - 1/22/2024 | 40.43% |
Heron Therapeuti (HRTX) | 1/2/2024 - 1/22/2024 | 39.29% |
Abacus Life (ABL) | 1/2/2024 - 1/22/2024 | 37.77% |
Yirendai (YRD) | 1/2/2024 - 1/22/2024 | 36.22% |
HighPeak Energy (HPKEW) | 1/2/2024 - 1/22/2024 | 35.75% |
Axogen (AXGN) | 1/2/2024 - 1/22/2024 | 33.73% |
Net Lease Office Properties (NLOP) | 1/2/2024 - 1/22/2024 | 33.52% |
Sana Biotechnology (SANA) | 1/2/2024 - 1/22/2024 | 32.76% |
Unisys (UIS) | 1/2/2024 - 1/22/2024 | 32.5% |
Tourmaline Bio (TRML) | 1/2/2024 - 1/22/2024 | 32.05% |
Verastem (VSTM) | 1/2/2024 - 1/22/2024 | 30.59% |
NRx Pharmaceuticals (NRXPW) | 1/2/2024 - 1/22/2024 | 29.56% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
